3.1 The Institute has issued interventional procedure guidance on: high-intensity focused ultrasound for prostate cancer, cryotherapy for recurrent prostate cancer, cryotherapy as a primary treatment for prostate cancer, low dose rate brachytherapy for localised prostate cancer and high dose rate brachytherapy in combination with external-beam radiotherapy for localised prostate cancer.
3.2 The Institute is also developing a clinical guideline on the diagnosis and treatment of prostate cancer (Now published as 'Prostate cancer: diagnosis and treatment').
The evidence considered by the Interventional Procedures Advisory Committee is described in the following document.
NICE has produced information on this procedure for patients and carers. It explains the nature of the procedure and the guidance issued by NICE, and has been written with patient consent in mind.